Michael Uhlin

Chief Scientific Officer at XNK Therapeutics

Professor Uhlin received his master’s degree in medical research with a focus on biomedicine from Karolinska Institutet (KI) in 2002 and his PhD in Infection Biology from KI in 2006. Since then, he has held several senior positions primarily within clinical immunology and cellular therapy at KI and Karolinska University Hospital, Stockholm, including serving as Head of Clinical Immunology, Department of Clinical Immunology and Transfusion Medicine at the Karolinska University Hospital.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


XNK Therapeutics

XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.


Industries

Headquarters

Huddinge, Sweden

Employees

11-50

Links